|Page (1) of 1 - 09/11/13||email article||print page|
LeMaitre Vascular to Host Two Investor and Analyst Days: November 12 & 13, 2013(September 11, 2013)
BURLINGTON, Mass., Sept. 11, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will host November 2013 investor and analyst days in two locations:
Tuesday, November 12, 9:30 AM to 1:00 PM EST, Corporate Headquarters, Burlington, MA
Wednesday, November 13, 9:30 AM to 12:30 PM PST, One Market Restaurant, San Francisco, CA
These two meetings are open to all investors and analysts. They will feature presentations by senior management who will discuss the Company's positioning and growth opportunities followed by question and answer sessions. Additionally, those who attend in Burlington, MA, will have the opportunity to participate in manufacturing facility tours and product demonstrations in the Company's R&D lab.
Please RSVP by Monday, November 4, 2013, via email to Mary Nielson, firstname.lastname@example.org.
Access to the live presentations will be available via phone and webcast. Please refer to the Investor Relations homepage on LeMaitre Vascular's website at www.lemaitre.com for specific access links and information.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at http://www.lemaitre.com.
LeMaitre, the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc.
Statements made at the upcoming conferences may contain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such "forward-looking statements" regarding the Company's business that are not historical facts may involve risks and uncertainties. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties that could cause actual results to differ from the results predicted. These risks and uncertainties include, but are not limited to, the risk that the Company may not realize the anticipated benefits of its strategic activities and other risks and uncertainties included under the heading "Risk Factors" in its most recent Annual Report on Form 10-K, as updated by its subsequent filings with the SEC, all of which are available on the Company's investor relations website at http://www.lemaitre.com and on the SEC's website at http://www.sec.gov. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. The Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.
CONTACT: LeMaitre Vascular, Inc.
Related Keywords: MEDICAL, WEBCASTPro AV, Post/Production, Management, Presentors, Management, Business, Business Issues, Internet Media, Presentation, Corporate/Company, People, Events, email, webcast, USA, Inc., Disease, healthcare, Surgery, Business, Email, Other,